1. Home
  2. IRON vs MLCO Comparison

IRON vs MLCO Comparison

Compare IRON & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$66.38

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Melco Resorts & Entertainment Limited

MLCO

Melco Resorts & Entertainment Limited

HOLD

Current Price

$6.12

Market Cap

2.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
MLCO
Founded
2017
2004
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
IRON
MLCO
Price
$66.38
$6.12
Analyst Decision
Strong Buy
Buy
Analyst Count
13
6
Target Price
$99.54
$9.42
AVG Volume (30 Days)
943.0K
2.7M
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.80
Revenue Next Year
$215.03
$4.40
P/E Ratio
N/A
$12.16
Revenue Growth
N/A
N/A
52 Week Low
$30.82
$4.55
52 Week High
$99.50
$10.15

Technical Indicators

Market Signals
Indicator
IRON
MLCO
Relative Strength Index (RSI) 43.58 49.31
Support Level $57.45 $5.88
Resistance Level $82.70 $6.54
Average True Range (ATR) 6.10 0.32
MACD 0.27 0.07
Stochastic Oscillator 73.52 78.26

Price Performance

Historical Comparison
IRON
MLCO

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About MLCO Melco Resorts & Entertainment Limited

Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao, with the rest largely from the Philippines as of 2024.

Share on Social Networks: